Literature DB >> 15009644

Identification of a residue in the gamma-aminobutyric acid type A receptor alpha subunit that differentially affects diazepam-sensitive and -insensitive benzodiazepine site binding.

Jason M C Derry1, Susan M J Dunn, Martin Davies.   

Abstract

GABAA receptors that contain either the alpha4- or alpha6-subunit isoform do not recognize classical 1,4-benzodiazepines (BZDs). However, other classes of BZD site ligands, including beta-carbolines, bind to these diazepam-insensitive receptor subtypes. Some beta-carbolines [e.g. ethyl beta-carboline-3-carboxylate (beta-CCE) and methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM)] display a higher affinity for alpha4- compared to alpha6-containing receptors. In order to identify the structural determinants that underlie these affinity differences, we constructed chimeric alpha6/alpha4 subunits and co-expressed these with wild-type rat beta2 and gamma2L subunits in tsA201 cells for radioligand binding analysis. After identification of candidate regions, site-directed mutagenesis was used to narrow the ligand selectivity to a single amino acid residue (alpha6N204/alpha4I203). Substitutions at alpha6N204 did not alter the affinity of the imidazobenzodiazepine Ro15-4513. A homologous mutation in the diazepam-sensitive alpha1 subunit (S205N) resulted in a 7-8-fold reduction in affinity for the beta-carbolines examined. Although the binding of the classical agonist flunitrazepam was relatively unaffected by this mutation in the alpha1 subunit, the affinity for Ro15-1788 and Ro15-4513 was decreased by approximately 19-fold and approximately 38-fold respectively. The importance of this residue, located in the Loop C region of the extracellular N-terminus of the subunit protein, emphasizes the differential interaction of ligands with the alpha subunit in diazepam-sensitive and -insensitive receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009644     DOI: 10.1046/j.1471-4159.2003.02264.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.

Authors:  Catherine Kulick; Samuel Gutherz; Alexei Kondratyev; Patrick A Forcelli
Journal:  Eur J Pharmacol       Date:  2014-06-23       Impact factor: 4.432

2.  Different residues in the GABAA receptor benzodiazepine binding pocket mediate benzodiazepine efficacy and binding.

Authors:  Elaine V Morlock; Cynthia Czajkowski
Journal:  Mol Pharmacol       Date:  2011-03-29       Impact factor: 4.436

3.  Cerebellar α6 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders.

Authors:  Lih-Chu Chiou; Hsin-Jung Lee; Margot Ernst; Wei-Jan Huang; Jui-Feng Chou; Hon-Lie Chen; Akihiro Mouri; Liang-Chieh Chen; Marco Treven; Takayoshi Mamiya; Pi-Chuan Fan; Daniel E Knutson; Chris Witzigmann; James Cook; Werner Sieghart; Toshitaka Nabeshima
Journal:  Br J Pharmacol       Date:  2018-05-10       Impact factor: 8.739

Review 4.  Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  Psychopharmacology (Berl)       Date:  2013-09-27       Impact factor: 4.530

Review 5.  Use of multicomponent reactions in developing small-molecule tools to study GABAA receptor mechanism and function.

Authors:  Ryan W Lewis; George P Hess; Bruce Ganem
Journal:  Future Med Chem       Date:  2011-02       Impact factor: 3.808

6.  Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic δGABA(A) Receptors.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

Review 7.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

8.  5-(N, N-Hexamethylene) amiloride is a GABA-A ρ1 receptor positive allosteric modulator.

Authors:  Heather D Snell; Eric B Gonzales
Journal:  Channels (Austin)       Date:  2016-07-01       Impact factor: 2.581

9.  Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different.

Authors:  Susan M Hanson; Elaine V Morlock; Kenneth A Satyshur; Cynthia Czajkowski
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

10.  Hispidulin alleviated methamphetamine-induced hyperlocomotion by acting at α6 subunit-containing GABAA receptors in the cerebellum.

Authors:  Yu-Hsiang Liao; Hsin-Jung Lee; Wei-Jan Huang; Pi-Chuan Fan; Lih-Chu Chiou
Journal:  Psychopharmacology (Berl)       Date:  2016-07-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.